NASDAQ:CLRB

Cellectar Biosciences Stock Predictions

etoro logo Buy CLRB
*Your capital is at risk
$2.74
-0.230 (-7.74%)
At Close: Jun 02, 2026
Currently predicting for Thu, 4 Jun 2026

CLRB Prediction Chart

CLRB Predictions History

Latest community submissions for CLRB.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 22, 2026 $3.78 +3.49% $3.81 V 99.15% 3
Jan 22, 2026 $3.73 +2.18% $3.81 V 97.89% 1
Jan 22, 2026 Bullish $3.81 V 1
Jun 13, 2025 $0.416 -4.73% $0.413 V 99.25% 3
Jun 13, 2025 $0.424 -2.96% $0.413 V 97.37% 1
Jun 13, 2025 Bullish $0.413 X 0
Jun 6, 2025 $0.410 +0.47% $0.361 X 86.36% 0
Jun 6, 2025 $0.388 -5.01% $0.361 V 92.56% 1
Jun 6, 2025 $0.395 -3.13% $0.361 V 90.43% 1
Jun 6, 2025 $0.80 +73.27% $0.361 X 0.00% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CLRB with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CELLECTAR BIOSCIENCES
Cellectar Biosciences
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE